Fundamentals

Valuation

Metric	Q4	Q2	Δ in %
EV/EBITDA	96.14	-1.35	-34.92
Graham Fair Price	451.95	0.51	0.09
PEG	-100.00	< 0.005	0.00
Price/Book	-0.63	0.49	0.49
Price/Cash Flow	-87.62	-3.35	27.04
Prices/Earnings	97.46	-0.91	-35.84
Price/Sales	-48.45	0.83	1.62
Price/FCF	-87.62	-3.35	27.04
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q2	Δ in %
Gross Profit Margin	291.28	-0.15	0.04
Operating Margin	-1506.10	-0.23	-0.01
ROA	-3439.36	-0.09	< 0.005
ROE	< 0.005	-0.13	-3815.59
ROIC	< 0.005	-0.13	-3146.76
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q2	Δ in %
Debt QOQ	-0.49	0.00	-100.00
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	0.00	-12.04	-100.00
EPS QOQ	0.00	-15.96	-100.00
FCF QOQ	0.00	-4.41	-100.00
Revenue QOQ	0.00	-0.15	-100.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2.60	11.73	351.58
Days Sales Outstanding (DSO)	0.00	164.04	100.00
Inventory Turnover	34.64	7.67	-77.86
Debt/Capitalization	0.06	0.01	-82.23
Quick Ratio	1.20	2.76	129.91
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q2	Δ in %
Book Value	0.33	0.29	-11.79
Cash	0.14	0.10	-32.59
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	-0.04	608.19
Revenue	0.10	0.17	70.02
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q2	Δ in %
Current Ratio	3.77	2.98	-21.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	80.36	2.27	-97.17
Naive Interpretation	Member

06 - Financial Health · Bad

Rating